- Leadership
- Program
- 2024 Program at a Glance
- 2023 Head & Neck Oncology Session
- 2023 GI Cancer Session
- 2023 Immuno Oncology Session
- 2023 Breast Imaging / Breast Surgical
- 2023 Breast Cancer Session
- 2023 Lung Cancer Session
- 2023 Uro Oncology Session
- 2023 Oncology Nursing Session
- 2023 Oncology Nutrition Session
- 2023 Palliative Care Session
- 2023 APMEA MTB Session
- 2023 Congress E-Brochure
- Speakers
- Partners
- Media
- Contact
- Webinars
- Journal Club
- About
- Upcoming JC
- Past Archived JC's
- 2024
- 2023
- February 13th Edition
- February 22nd Edition
- February 28th Edition
- March 6th Edition
- March 20th Edition
- April 17th Edition
- May 08th Edition
- May 17th Edition
- May 29th Edition
- June 12th Edition
- June 22nd Edition
- June 23rd Edition
- August 14th Edition
- September 7th Edition
- September 18th Edition
- October 16th Edition
- November 23rd Edition
- December 12th Edition
- 2022
- 2021
- 2020
- In Conversation
- In Conversation Series
- Journal Club
- Register Now
- Day 3 Access
- Young Leaders in Oncology
- Submit Interest
Hamdy A. Azim
Clinical Oncologist, Egypt
Dr Azim is a Professor of Clinical Oncology and immediate past chairman of the Department of Clinical Oncology, Faculty of Medicine, Cairo University. He is the president of the Cairo Oncology Center, one of the largest private Cancer centers in the Middle East region. Dr Azim chairs the scientific committee of the NCCN Middle East chapter and is a member of numerous societies, including the ASCO, ASH, ESMO, ASTRO and the European Blood and Marrow Transplantation Society. He has been principal investigator for many multicenter clinical trials and has published more than 80 papers and he was the chief editor of 2 educational books ( ASCO – PANARAB Lymphoma Conference (1999) and the MD Anderson Cancer Centre / Cairo University joint meeting (2006). Dr Azim serves as a referee for the Annals of Oncology Journal, THE BREAST, BMC Cancer, Chemotherapy journal , Advances in Cancer Research & Treatment, Journal of the Egyptian National Cancer Institute, and the Chinese Clinical Oncology Journal.